+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Current treatment in high risk and locally advanced prostate cancer

Current treatment in high risk and locally advanced prostate cancer

Actas Urologicas Espanolas 31(5): 445-451

Treatment of locally advanced prostate cancer remains controversial. Treatment options include radical prostatectomy (PR), radiotherapy (RT) and hormonotherapy (HT). A Medline database search with key words "prostate cancer", "locally advanced", "high risk" and "treatment" in articles published during the last 15 years was done. Fifty one out of 329 papers were selected and reviewed. Selection criteria were a minimum of scientific evidence level of IIa, except for some specific level IV reference. Numerous randomized studies show that patients may benefit of a combined therapy with RT and HT. RP has shown its usefulness in selected cases of locally advanced prostate cancer. Results of long follow-up series are similar to those obtained with RT and HT. Furthermore, the possibility of clinical over staging is an argument in favour of RP. We perform an updated revision of every possible choice available in the treatment of these tumours.

(PDF emailed within 1 workday: $29.90)

Accession: 052414556

Download citation: RISBibTeXText

PMID: 17711162

Related references

Current trends for the use of androgen deprivation therapy in conjunction with radiotherapy for patients with unfavorable intermediate-risk, high-risk, localized, and locally advanced prostate cancer. Cancer 120(11): 1620-1629, 2014

Phase III study for local or locally advanced prostate cancer : Randomized, double-blind, placebo-controlled phase 3 study of apalutamide in patients with local high-risk prostate cancer or locally advanced prostate cancer receiving primary radiotherapy (ATLAS) - study AP 90/15 of the AUO. Der Urologe. Ausg. a 56(2): 243-244, 2017

Man With Locally Advanced, High-Risk Prostate Cancer Asks About Adding Chemotherapy to His Treatment. Oncology 30(1): 94-98, 2016

Impact of cancer service centralisation on the radical treatment of men with high-risk and locally advanced prostate cancer: A national cross-sectional analysis in England. International Journal of Cancer 2018, 2018

Chemotherapy at First Diagnosis of Advanced Prostate Cancer - Revolution or Evolution? Findings from a British Uro-oncology Group UK Survey to Evaluate Oncologists' Views on First-line Docetaxel in Combination with Androgen Deprivation Therapy in Castrate-sensitive Metastatic and High-risk/Locally Advanced Prostate Cancer. Clinical Oncology ) 28(6): 376-385, 2017

Should Treatment with Radiation and Androgen Deprivation Therapy be Considered the 'Gold Standard' for Men with Unfavourable Intermediate- to High-risk and Locally Advanced Prostate Cancer?. Clinical Oncology ) 28(8): 475-478, 2016

Current treatment of locally advanced and metastatic prostate cancer. Wiener Medizinische Wochenschrift 161(15-16): 377-381, 2012

What constitutes high-risk locally advanced prostate cancer?. Clinical Genitourinary Cancer 4(3): 193-196, 2006

ACR Appropriateness Criteria® Locally Advanced, High-Risk Prostate Cancer. American Journal of Clinical Oncology 40(1): 1-10, 2017

Management of high-risk populations with locally advanced prostate cancer. Oncologist 8(3): 259-269, 2003

The importance of surgery in locally advanced very high risk prostate cancer. European Urology Supplements 15(11): E1402-E1403, 2016

Radiotherapy before and after radical prostatectomy for high-risk and locally advanced prostate cancer. Urologic Oncology 33(5): 226-234, 2016

The management of high-risk, locally advanced, prostate cancer radiation therapy. Canadian Urological Association Journal 6(5): 393-395, 2012

The importance of local control in high-risk locally advanced prostate cancer. Current Oncology 19(Suppl 3): S6-S12, 2013

Locally advanced and high risk prostate cancer: The best indication for initial radical prostatectomy?. Asian Journal of Urology 1(1): 40-45, 2014